OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Contribution of Epigenetics to Cancer Immunotherapy
Lorea Villanueva, Damiana Álvarez‐Errico, Manel Esteller
Trends in Immunology (2020) Vol. 41, Iss. 8, pp. 676-691
Open Access | Times Cited: 188
Lorea Villanueva, Damiana Álvarez‐Errico, Manel Esteller
Trends in Immunology (2020) Vol. 41, Iss. 8, pp. 676-691
Open Access | Times Cited: 188
Showing 1-25 of 188 citing articles:
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma, Bilal A. Siddiqui, Swetha Anandhan, et al.
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 838-857
Open Access | Times Cited: 544
Padmanee Sharma, Bilal A. Siddiqui, Swetha Anandhan, et al.
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 838-857
Open Access | Times Cited: 544
Evolving therapeutic landscape of advanced hepatocellular carcinoma
Chen Yang, Hailin Zhang, Linmeng Zhang, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 4, pp. 203-222
Closed Access | Times Cited: 429
Chen Yang, Hailin Zhang, Linmeng Zhang, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 4, pp. 203-222
Closed Access | Times Cited: 429
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
Cancer epigenetics in clinical practice
Verónica Dávalos, Manel Esteller
CA A Cancer Journal for Clinicians (2022) Vol. 73, Iss. 4, pp. 376-424
Open Access | Times Cited: 146
Verónica Dávalos, Manel Esteller
CA A Cancer Journal for Clinicians (2022) Vol. 73, Iss. 4, pp. 376-424
Open Access | Times Cited: 146
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 143
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 143
Epigenome-wide association study of COVID-19 severity with respiratory failure
Manuel Castro de Moura, Verónica Dávalos, Laura Planas‐Serra, et al.
EBioMedicine (2021) Vol. 66, pp. 103339-103339
Open Access | Times Cited: 129
Manuel Castro de Moura, Verónica Dávalos, Laura Planas‐Serra, et al.
EBioMedicine (2021) Vol. 66, pp. 103339-103339
Open Access | Times Cited: 129
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology (2022) Vol. 23, Iss. 9, pp. 1379-1392
Open Access | Times Cited: 78
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology (2022) Vol. 23, Iss. 9, pp. 1379-1392
Open Access | Times Cited: 78
Immunotherapy for head and neck cancer: Present and future
Morena Fasano, Carminia Maria Della Corte, Raimondo Di Liello, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 174, pp. 103679-103679
Open Access | Times Cited: 74
Morena Fasano, Carminia Maria Della Corte, Raimondo Di Liello, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 174, pp. 103679-103679
Open Access | Times Cited: 74
The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms
Qibo Huang, Jie Mo, Zhibin Liao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 73
Qibo Huang, Jie Mo, Zhibin Liao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 73
Current State of Cold Atmospheric Plasma and Cancer‐Immunity Cycle: Therapeutic Relevance and Overcoming Clinical Limitations Using Hydrogels
Milica Živanić, Albert Espona‐Noguera, Abraham Lin, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 43
Milica Živanić, Albert Espona‐Noguera, Abraham Lin, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 43
An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review
Zahra Sahafnejad, Shahin Ramazi, Abdollah Allahverdi
Genes (2023) Vol. 14, Iss. 4, pp. 873-873
Open Access | Times Cited: 43
Zahra Sahafnejad, Shahin Ramazi, Abdollah Allahverdi
Genes (2023) Vol. 14, Iss. 4, pp. 873-873
Open Access | Times Cited: 43
Pharmacological targeting of the cancer epigenome
Nathaniel W. Mabe, Jennifer A. Perry, Clare F. Malone, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 844-865
Closed Access | Times Cited: 19
Nathaniel W. Mabe, Jennifer A. Perry, Clare F. Malone, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 844-865
Closed Access | Times Cited: 19
The Epigenetic Hallmarks of Cancer
Manel Esteller, Mark A. Dawson, Cigall Kadoch, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1783-1809
Closed Access | Times Cited: 16
Manel Esteller, Mark A. Dawson, Cigall Kadoch, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1783-1809
Closed Access | Times Cited: 16
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
Daniele Tavernari, Elena Battistello, Elie Dheilly, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1490-1507
Open Access | Times Cited: 99
Daniele Tavernari, Elena Battistello, Elie Dheilly, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1490-1507
Open Access | Times Cited: 99
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
Laura Boyero, Amparo Sánchez-Gastaldo, Miriam Alonso, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3729-3729
Open Access | Times Cited: 77
Laura Boyero, Amparo Sánchez-Gastaldo, Miriam Alonso, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3729-3729
Open Access | Times Cited: 77
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity
Zhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 11, pp. 1320-1335
Open Access | Times Cited: 76
Zhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 11, pp. 1320-1335
Open Access | Times Cited: 76
The epitranscriptome toolbox
Sharon Moshitch-Moshkovitz, Dan Dominissini, Gideon Rechavi
Cell (2022) Vol. 185, Iss. 5, pp. 764-776
Open Access | Times Cited: 66
Sharon Moshitch-Moshkovitz, Dan Dominissini, Gideon Rechavi
Cell (2022) Vol. 185, Iss. 5, pp. 764-776
Open Access | Times Cited: 66
The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy
Yunkai Yang, Min Zhang, Yan Wang
Journal of the National Cancer Center (2022) Vol. 2, Iss. 4, pp. 277-290
Open Access | Times Cited: 59
Yunkai Yang, Min Zhang, Yan Wang
Journal of the National Cancer Center (2022) Vol. 2, Iss. 4, pp. 277-290
Open Access | Times Cited: 59
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 58
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 58
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
Dimitrios C. Ziogas, Charalampos Theocharopoulos, Tilemachos Koutouratsas, et al.
Cancer Treatment Reviews (2022) Vol. 113, pp. 102499-102499
Closed Access | Times Cited: 57
Dimitrios C. Ziogas, Charalampos Theocharopoulos, Tilemachos Koutouratsas, et al.
Cancer Treatment Reviews (2022) Vol. 113, pp. 102499-102499
Closed Access | Times Cited: 57
Epigenetic remodelling in human hepatocellular carcinoma
Maria Rita Braghini, Oriana Lo Re, Ilaria Romito, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 50
Maria Rita Braghini, Oriana Lo Re, Ilaria Romito, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 50
The paradigm of drug resistance in cancer: an epigenetic perspective
Swagata Adhikari, Apoorva Bhattacharya, Santanu Adhikary, et al.
Bioscience Reports (2022) Vol. 42, Iss. 4
Open Access | Times Cited: 45
Swagata Adhikari, Apoorva Bhattacharya, Santanu Adhikary, et al.
Bioscience Reports (2022) Vol. 42, Iss. 4
Open Access | Times Cited: 45
Epigenetic reprogramming in cancer: From diagnosis to treatment
Pedro M. S. Costa, Sarah Leyenne Alves Sales, Daniel Pascoalino Pinheiro, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 34
Pedro M. S. Costa, Sarah Leyenne Alves Sales, Daniel Pascoalino Pinheiro, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 34
Genetic mechanisms of fertilization failure and early embryonic arrest: a comprehensive review
Yiqiu Wei, Jingxuan Wang, Rui Qu, et al.
Human Reproduction Update (2023) Vol. 30, Iss. 1, pp. 48-80
Closed Access | Times Cited: 28
Yiqiu Wei, Jingxuan Wang, Rui Qu, et al.
Human Reproduction Update (2023) Vol. 30, Iss. 1, pp. 48-80
Closed Access | Times Cited: 28
